VIP2_HUMAN - dbPTM
VIP2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID VIP2_HUMAN
UniProt AC O43314
Protein Name Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2
Gene Name PPIP5K2
Organism Homo sapiens (Human).
Sequence Length 1243
Subcellular Localization Cytoplasm, cytosol .
Protein Description Bifunctional inositol kinase that acts in concert with the IP6K kinases IP6K1, IP6K2 and IP6K3 to synthesize the diphosphate group-containing inositol pyrophosphates diphosphoinositol pentakisphosphate, PP-InsP5, and bis-diphosphoinositol tetrakisphosphate, (PP)2-InsP4. PP-InsP5 and (PP)2-InsP4, also respectively called InsP7 and InsP8, regulate a variety of cellular processes, including apoptosis, vesicle trafficking, cytoskeletal dynamics, exocytosis, insulin signaling and neutrophil activation. Phosphorylates inositol hexakisphosphate (InsP6) at positions 1 or 3 to produce PP-InsP5 which is in turn phosphorylated by IP6Ks to produce (PP)2-InsP4. Alternatively, phosphorylates at position 1 or 3 PP-InsP5, produced by IP6Ks from InsP6, to produce (PP)2-InsP4..
Protein Sequence MSEAPRFFVGPEDTEINPGNYRHFFHHADEDDEEEDDSPPERQIVVGICSMAKKSKSKPMKEILERISLFKYITVVVFEEEVILNEPVENWPLCDCLISFHSKGFPLDKAVAYAKLRNPFVINDLNMQYLIQDRREVYSILQAEGILLPRYAILNRDPNNPKECNLIEGEDHVEVNGEVFQKPFVEKPVSAEDHNVYIYYPTSAGGGSQRLFRKIGSRSSVYSPESNVRKTGSYIYEEFMPTDGTDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEVRYPVILNAREKLIAWKVCLAFKQTVCGFDLLRANGQSYVCDVNGFSFVKNSMKYYDDCAKILGNIVMRELAPQFHIPWSIPLEAEDIPIVPTTSGTMMELRCVIAVIRHGDRTPKQKMKMEVRHQKFFDLFEKCDGYKSGKLKLKKPKQLQEVLDIARQLLMELGQNNDSEIEENKPKLEQLKTVLEMYGHFSGINRKVQLTYLPHGCPKTSSEEEDSRREEPSLLLVLKWGGELTPAGRVQAEELGRAFRCMYPGGQGDYAGFPGCGLLRLHSTYRHDLKIYASDEGRVQMTAAAFAKGLLALEGELTPILVQMVKSANMNGLLDSDSDSLSSCQQRVKARLHEILQKDRDFTAEDYEKLTPSGSISLIKSMHLIKNPVKTCDKVYSLIQSLTSQIRHRMEDPKSSDIQLYHSETLELMLRRWSKLEKDFKTKNGRYDISKIPDIYDCIKYDVQHNGSLKLENTMELYRLSKALADIVIPQEYGITKAEKLEIAKGYCTPLVRKIRSDLQRTQDDDTVNKLHPVYSRGVLSPERHVRTRLYFTSESHVHSLLSILRYGALCNESKDEQWKRAMDYLNVVNELNYMTQIVIMLYEDPNKDLSSEERFHVELHFSPGAKGCEEDKNLPSGYGYRPASRENEGRRPFKIDNDDEPHTSKRDEVDRAVILFKPMVSEPIHIHRKSPLPRSRKTATNDEESPLSVSSPEGTGTWLHYTSGVGTGRRRRRSGEQITSSPVSPKSLAFTSSIFGSWQQVVSENANYLRTPRTLVEQKQNPTVGSHCAGLFSTSVLGGSSSAPNLQDYARTHRKKLTSSGCIDDATRGSAVKRFSISFARHPTNGFELYSMVPSICPLETLHNALSLKQVDEFLASIASPSSDVPRKTAEISSTALRSSPIMRKKVSLNTYTPAKILPTPPATLKSTKASSKPATSGPSSAVVPNTSSRKKNITSKTETHEHKKNTGKKK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
14PhosphorylationFFVGPEDTEINPGNY
EECCCCCCCCCCCCC
36.78-
21PhosphorylationTEINPGNYRHFFHHA
CCCCCCCCCCEEECC
16.0429978859
38PhosphorylationDDEEEDDSPPERQIV
CCCCCCCCCCHHHHH
55.4620201521
50PhosphorylationQIVVGICSMAKKSKS
HHHHHHHHHHHHCCC
21.6125278378
55PhosphorylationICSMAKKSKSKPMKE
HHHHHHHCCCCCHHH
41.2625278378
61AcetylationKSKSKPMKEILERIS
HCCCCCHHHHHHHHH
50.5618586523
68PhosphorylationKEILERISLFKYITV
HHHHHHHHHHHEEEE
33.6924719451
115UbiquitinationDKAVAYAKLRNPFVI
HHHHHHHHHCCCEEE
34.99-
219PhosphorylationFRKIGSRSSVYSPES
HHHHCCCCCCCCCCC
26.3427732954
220PhosphorylationRKIGSRSSVYSPESN
HHHCCCCCCCCCCCC
24.7827732954
222PhosphorylationIGSRSSVYSPESNVR
HCCCCCCCCCCCCCC
22.0626852163
223PhosphorylationGSRSSVYSPESNVRK
CCCCCCCCCCCCCCC
21.7528985074
226PhosphorylationSSVYSPESNVRKTGS
CCCCCCCCCCCCCCC
43.9726852163
230UbiquitinationSPESNVRKTGSYIYE
CCCCCCCCCCCEEEE
53.61-
248AcetylationPTDGTDVKVYTVGPD
CCCCCCEEEEEECCC
32.1320167786
250PhosphorylationDGTDVKVYTVGPDYA
CCCCEEEEEECCCCH
7.0328796482
251PhosphorylationGTDVKVYTVGPDYAH
CCCEEEEEECCCCHH
23.2128796482
256PhosphorylationVYTVGPDYAHAEARK
EEEECCCCHHHHHHC
11.9228796482
263UbiquitinationYAHAEARKSPALDGK
CHHHHHHCCCCCCCC
68.77-
270AcetylationKSPALDGKVERDSEG
CCCCCCCCEEECCCC
40.3620167786
270UbiquitinationKSPALDGKVERDSEG
CCCCCCCCEEECCCC
40.36-
333UbiquitinationSFVKNSMKYYDDCAK
EEECCCCCHHHHHHH
40.24-
334PhosphorylationFVKNSMKYYDDCAKI
EECCCCCHHHHHHHH
11.9529496907
335PhosphorylationVKNSMKYYDDCAKIL
ECCCCCHHHHHHHHH
10.37-
406UbiquitinationKMEVRHQKFFDLFEK
HHHHHHHHHHHHHHH
41.70-
482PhosphorylationINRKVQLTYLPHGCP
CCCEEEEEECCCCCC
13.1128634298
483PhosphorylationNRKVQLTYLPHGCPK
CCEEEEEECCCCCCC
27.1623927012
491PhosphorylationLPHGCPKTSSEEEDS
CCCCCCCCCCHHHHH
23.7223401153
492PhosphorylationPHGCPKTSSEEEDSR
CCCCCCCCCHHHHHH
41.7130266825
493PhosphorylationHGCPKTSSEEEDSRR
CCCCCCCCHHHHHHC
55.0123401153
498PhosphorylationTSSEEEDSRREEPSL
CCCHHHHHHCCCCCE
36.2023927012
504PhosphorylationDSRREEPSLLLVLKW
HHHCCCCCEEEEEEE
34.6223898821
541PhosphorylationYPGGQGDYAGFPGCG
CCCCCCCCCCCCCCC
18.5621945579
561UbiquitinationSTYRHDLKIYASDEG
CEECCEEEEEECCCC
39.46-
563PhosphorylationYRHDLKIYASDEGRV
ECCEEEEEECCCCCH
9.8528064214
573PhosphorylationDEGRVQMTAAAFAKG
CCCCHHHHHHHHHHH
8.96-
589PhosphorylationLALEGELTPILVQMV
HHHCCCCHHHHHHHH
12.18-
629UbiquitinationRLHEILQKDRDFTAE
HHHHHHHHCCCCCHH
51.81-
640UbiquitinationFTAEDYEKLTPSGSI
CCHHHHHHCCCCCCH
51.97-
646PhosphorylationEKLTPSGSISLIKSM
HHCCCCCCHHHHHHH
17.2227067055
648PhosphorylationLTPSGSISLIKSMHL
CCCCCCHHHHHHHHH
26.2424719451
672PhosphorylationKVYSLIQSLTSQIRH
HHHHHHHHHHHHHHH
26.9921955146
674PhosphorylationYSLIQSLTSQIRHRM
HHHHHHHHHHHHHHC
24.6721955146
675PhosphorylationSLIQSLTSQIRHRME
HHHHHHHHHHHHHCC
28.9821955146
686PhosphorylationHRMEDPKSSDIQLYH
HHCCCCCCCCCEEEC
38.3320068231
687PhosphorylationRMEDPKSSDIQLYHS
HCCCCCCCCCEEECH
44.8820068231
692PhosphorylationKSSDIQLYHSETLEL
CCCCCEEECHHHHHH
6.2120068231
694PhosphorylationSDIQLYHSETLELML
CCCEEECHHHHHHHH
20.7920068231
696PhosphorylationIQLYHSETLELMLRR
CEEECHHHHHHHHHH
28.6620068231
705PhosphorylationELMLRRWSKLEKDFK
HHHHHHHHHHHHHHC
26.0820068231
727PhosphorylationISKIPDIYDCIKYDV
HHHCCCHHHHHCCCC
16.4923917254
732PhosphorylationDIYDCIKYDVQHNGS
CHHHHHCCCCCCCCC
11.0524114839
739PhosphorylationYDVQHNGSLKLENTM
CCCCCCCCEEEECHH
27.8724114839
768UbiquitinationPQEYGITKAEKLEIA
CHHHCCCHHHHHHHH
53.26-
778PhosphorylationKLEIAKGYCTPLVRK
HHHHHCCCCHHHHHH
7.76-
780PhosphorylationEIAKGYCTPLVRKIR
HHHCCCCHHHHHHHH
15.9228348404
788PhosphorylationPLVRKIRSDLQRTQD
HHHHHHHHHHHHCCC
46.2627067055
801UbiquitinationQDDDTVNKLHPVYSR
CCCCHHHHCCCCCCC
43.78-
806PhosphorylationVNKLHPVYSRGVLSP
HHHCCCCCCCCCCCC
9.3329978859
807PhosphorylationNKLHPVYSRGVLSPE
HHCCCCCCCCCCCCC
23.8529978859
812PhosphorylationVYSRGVLSPERHVRT
CCCCCCCCCCCCCCE
23.4724719451
822PhosphorylationRHVRTRLYFTSESHV
CCCCEEEEECCHHHH
11.0829083192
824PhosphorylationVRTRLYFTSESHVHS
CCEEEEECCHHHHHH
20.3029083192
825PhosphorylationRTRLYFTSESHVHSL
CEEEEECCHHHHHHH
27.4829083192
827PhosphorylationRLYFTSESHVHSLLS
EEEECCHHHHHHHHH
30.4929083192
831PhosphorylationTSESHVHSLLSILRY
CCHHHHHHHHHHHHH
29.8929083192
834PhosphorylationSHVHSLLSILRYGAL
HHHHHHHHHHHHHHH
25.5229083192
894PhosphorylationFHVELHFSPGAKGCE
EEEEEEECCCCCCCC
16.2129214152
916PhosphorylationGYGYRPASRENEGRR
CCCCCCCCCCCCCCC
42.6928555341
926UbiquitinationNEGRRPFKIDNDDEP
CCCCCCCCCCCCCCC
52.40-
949AcetylationDRAVILFKPMVSEPI
CEEEEEEECCCCCCE
28.8525953088
953PhosphorylationILFKPMVSEPIHIHR
EEEECCCCCCEEECC
31.2528555341
962PhosphorylationPIHIHRKSPLPRSRK
CEEECCCCCCCCCCC
31.4627251275
977PhosphorylationTATNDEESPLSVSSP
CCCCCCCCCCCCCCC
29.1528450419
980PhosphorylationNDEESPLSVSSPEGT
CCCCCCCCCCCCCCC
24.2830576142
982PhosphorylationEESPLSVSSPEGTGT
CCCCCCCCCCCCCCC
36.4830576142
983PhosphorylationESPLSVSSPEGTGTW
CCCCCCCCCCCCCCE
25.4728450419
987PhosphorylationSVSSPEGTGTWLHYT
CCCCCCCCCCEEEEE
29.7623186163
989PhosphorylationSSPEGTGTWLHYTSG
CCCCCCCCEEEEECC
25.3723186163
993PhosphorylationGTGTWLHYTSGVGTG
CCCCEEEEECCCCCC
10.63-
999PhosphorylationHYTSGVGTGRRRRRS
EEECCCCCCCCCCCC
25.71-
1006PhosphorylationTGRRRRRSGEQITSS
CCCCCCCCCCCCCCC
44.8919664994
1011PhosphorylationRRSGEQITSSPVSPK
CCCCCCCCCCCCCHH
23.8930266825
1012PhosphorylationRSGEQITSSPVSPKS
CCCCCCCCCCCCHHH
33.9830266825
1013PhosphorylationSGEQITSSPVSPKSL
CCCCCCCCCCCHHHH
22.2230266825
1016PhosphorylationQITSSPVSPKSLAFT
CCCCCCCCHHHHHEE
29.9629255136
1029PhosphorylationFTSSIFGSWQQVVSE
EEHHHHCCHHHHHHC
15.8024719451
1043PhosphorylationENANYLRTPRTLVEQ
CCCCCCCCCCCHHHC
17.9625627689
1046PhosphorylationNYLRTPRTLVEQKQN
CCCCCCCCHHHCCCC
36.0422210691
1055PhosphorylationVEQKQNPTVGSHCAG
HHCCCCCCCCHHHCC
45.0828450419
1058PhosphorylationKQNPTVGSHCAGLFS
CCCCCCCHHHCCHHC
15.8528450419
1065PhosphorylationSHCAGLFSTSVLGGS
HHHCCHHCCCCCCCC
25.4728450419
1066PhosphorylationHCAGLFSTSVLGGSS
HHCCHHCCCCCCCCC
18.6026657352
1067PhosphorylationCAGLFSTSVLGGSSS
HCCHHCCCCCCCCCC
17.7228450419
1072PhosphorylationSTSVLGGSSSAPNLQ
CCCCCCCCCCCCCHH
21.2228450419
1072O-linked_GlycosylationSTSVLGGSSSAPNLQ
CCCCCCCCCCCCCHH
21.22OGP
1073PhosphorylationTSVLGGSSSAPNLQD
CCCCCCCCCCCCHHH
33.5221712546
1074PhosphorylationSVLGGSSSAPNLQDY
CCCCCCCCCCCHHHH
49.8225159151
1081PhosphorylationSAPNLQDYARTHRKK
CCCCHHHHHHHHHHH
5.7524043423
1090PhosphorylationRTHRKKLTSSGCIDD
HHHHHHCCCCCCCCC
29.7128450419
1091PhosphorylationTHRKKLTSSGCIDDA
HHHHHCCCCCCCCCC
34.8625159151
1092PhosphorylationHRKKLTSSGCIDDAT
HHHHCCCCCCCCCCC
32.2328450419
1099PhosphorylationSGCIDDATRGSAVKR
CCCCCCCCCCCCCEE
42.4228102081
1100MethylationGCIDDATRGSAVKRF
CCCCCCCCCCCCEEE
38.50115488345
1102PhosphorylationIDDATRGSAVKRFSI
CCCCCCCCCCEEEEE
26.9728102081
1108PhosphorylationGSAVKRFSISFARHP
CCCCEEEEEEEEECC
22.7430266825
1110PhosphorylationAVKRFSISFARHPTN
CCEEEEEEEEECCCC
16.2022617229
1139PhosphorylationETLHNALSLKQVDEF
HHHHHHHCHHHHHHH
30.9824719451
1149PhosphorylationQVDEFLASIASPSSD
HHHHHHHHHCCCCCC
22.3428348404
1151PhosphorylationDEFLASIASPSSDVP
HHHHHHHCCCCCCCC
16.9424719451
1152PhosphorylationEFLASIASPSSDVPR
HHHHHHCCCCCCCCC
24.5225159151
1159PhosphorylationSPSSDVPRKTAEISS
CCCCCCCCCHHHCCH
49.1324719451
1160UbiquitinationPSSDVPRKTAEISST
CCCCCCCCHHHCCHH
46.12-
1161PhosphorylationSSDVPRKTAEISSTA
CCCCCCCHHHCCHHH
30.7023403867
1164PhosphorylationVPRKTAEISSTALRS
CCCCHHHCCHHHHHC
3.5024719451
1165PhosphorylationPRKTAEISSTALRSS
CCCHHHCCHHHHHCC
17.0923401153
1166PhosphorylationRKTAEISSTALRSSP
CCHHHCCHHHHHCCC
24.3023401153
1167PhosphorylationKTAEISSTALRSSPI
CHHHCCHHHHHCCCC
23.9523401153
1171PhosphorylationISSTALRSSPIMRKK
CCHHHHHCCCCCCCC
41.1223401153
1172PhosphorylationSSTALRSSPIMRKKV
CHHHHHCCCCCCCCC
16.4125159151
1180PhosphorylationPIMRKKVSLNTYTPA
CCCCCCCCCCCCCCC
25.4525159151
1183PhosphorylationRKKVSLNTYTPAKIL
CCCCCCCCCCCCCCC
33.7828796482
1184PhosphorylationKKVSLNTYTPAKILP
CCCCCCCCCCCCCCC
15.0628796482
1185PhosphorylationKVSLNTYTPAKILPT
CCCCCCCCCCCCCCC
18.0925159151
1192PhosphorylationTPAKILPTPPATLKS
CCCCCCCCCCCCCCC
38.1621815630
1196PhosphorylationILPTPPATLKSTKAS
CCCCCCCCCCCCCCC
40.2626074081
1198MethylationPTPPATLKSTKASSK
CCCCCCCCCCCCCCC
52.29115975521
1198PhosphorylationPTPPATLKSTKASSK
CCCCCCCCCCCCCCC
52.2924719451
1199PhosphorylationTPPATLKSTKASSKP
CCCCCCCCCCCCCCC
37.9526074081
1200PhosphorylationPPATLKSTKASSKPA
CCCCCCCCCCCCCCC
29.1026074081
1201MethylationPATLKSTKASSKPAT
CCCCCCCCCCCCCCC
54.05115975527
1209O-linked_GlycosylationASSKPATSGPSSAVV
CCCCCCCCCCCCCCC
51.3031492838
1219PhosphorylationSSAVVPNTSSRKKNI
CCCCCCCCCCCCCCC
23.2425262027
1220PhosphorylationSAVVPNTSSRKKNIT
CCCCCCCCCCCCCCC
34.4825262027
1221PhosphorylationAVVPNTSSRKKNITS
CCCCCCCCCCCCCCC
46.1925627689

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of VIP2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of VIP2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of VIP2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
WDR74_HUMANWDR74physical
22939629
WDR6_HUMANWDR6physical
22939629
ZC3HF_HUMANZC3H15physical
22939629
ZBT8B_HUMANZBTB8Bphysical
22939629
LUZP1_HUMANLUZP1physical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of VIP2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-38 AND SER-1006, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-38; SER-1006; SER-1016AND SER-1172, AND MASS SPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-504, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-38, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1185, AND MASSSPECTROMETRY.

TOP